“…Two L. donovani specific proteins, termed gp70-2 and dp72, were recognized in a direct dot-blot assay, with 90% and 100% sensitivity, and 984% and 93% specificity, respectively (Jaffe & Zalis 1988). In previous studies, a major surface glycoprotein, termed gp63, identified on several Leishmania species (Lepay, Nogueira & Cohn 1983, Gardiner, Jaffe & Dwyer 1984, Colomer-Gould et al 1985, Bouvier, Etges & Bordier 1987, Campbell, Kurath & Fleischman 1992, was found to elicit a strong humoral immune response during VL, CL and MCL infections (Lepay, Nogueira & Cohn 1983, Colomer-Gould et al 1985, Lemesre et al 1985, Reed, Badaro & Cheri-Lloyd 1987, Kutner et al 1991). It appears that the L. chagasi (and L. donovani) recombinant gp63 was also recognized by VL patient sera in a protein A-ELISA test (Reed et al 1990), with 84% sensitivity, and 100% specificity (Schreffler et al 1993).…”